Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenges case » challenges pose (Expand Search), challenges raised (Expand Search), challenges faced (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenges case » challenges pose (Expand Search), challenges raised (Expand Search), challenges faced (Expand Search)
-
421
-
422
-
423
-
424
-
425
-
426
-
427
-
428
-
429
-
430
-
431
-
432
-
433
-
434
-
435
-
436
-
437
-
438
-
439
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
440